AVEO Oncology reports full year 2014 financial results
AVEO Oncology reported the net loss for 2014 was $52.7 million, or a net loss of $1.01 per basic and diluted share versus a net loss of $107.0 million or a net loss of $2.10 per basic and diluted share for 2013. AVEO ended 2014 with $52.3 million in cash and cash equivalents. March 06, 2015